# REPAGLINIDE
> **ANDA091517** · Abbreviated New Drug Application (Generic) · Sponsor: KENTON · Approved 2015-04-24
## Drug
- **FDA Application Number:** ANDA091517
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** REPAGLINIDE
- **Generic name:** Repaglinide
- **Active ingredients:** REPAGLINIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** KENTON
- **First approval:** 2015-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091517)
---
*AI Analytics · CC0 1.0*